Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Brian Stansell

Pediatrics Birmingham, AL Medical Doctor

NPI 1841230729 CMS profile 672190

2815 Independence Dr, Birmingham, AL 35209

Open in the dashboard

General payments

$19,089

397 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Brian Stansell of Birmingham, AL is reported in the CMS Open Payments database as having received $19,089 across 397 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Pediatrics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $8,088 92
2024 General $1,618 61
2023 General $2,928 49
2022 General $1,126 67
2021 General $850 50
2020 General $586 34
2019 General $3,892 44

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Brian Stansell
  • Pediatrics median
  • Middle half of Pediatrics
  • National median

In program year 2025, general payments to Brian Stansell were reported at $8,088. Among 22,296 Pediatrics profiles paid that year, the median was $97 and the middle half received between $37 and $210.

Show as a table
Year Brian Stansell Pediatrics median Middle half National median
2019 $3,892 $86 $31–$183 $163
2020 $586 $49 $22–$110 $114
2021 $850 $68 $27–$158 $132
2022 $1,126 $77 $30–$173 $149
2023 $2,928 $88 $33–$190 $160
2024 $1,618 $94 $34–$206 $164
2025 $8,088 $97 $37–$210 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. ALK-Abello, Inc $6,788 36 payments
  2. Supernus Pharmaceuticals, Inc. $4,272 58 payments
  3. Corium, Inc. $2,898 54 payments
  4. Ironshore Pharmaceuticals Inc. $1,316 56 payments
  5. Tris Pharma Inc $542 30 payments
  6. Neos Therapeutics, LP $522 33 payments
  7. GlaxoSmithKline, LLC. $318 9 payments
  8. Kowa Pharmaceuticals America, Inc. $260 18 payments
  9. Sanofi-Aventis U.S. LLC $260 7 payments
  10. Sanofi Pasteur Inc. $234 7 payments
  11. Other $1,680 89 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $8,597 385 payments
  2. Honoraria $4,980 2 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $3,400 2 payments
  4. Travel and Lodging $1,796 6 payments
  5. Consulting Fee $300 1 payment
  6. Education $17 1 payment
Products named General payments · program years 2019–2025
  1. Odactra $6,788 36 payments
  2. Azstarys $2,898 54 payments
  3. Qelbree $1,001 31 payments
  4. Grastek $544 29 payments
  5. Jornay PM 20mg capsules (Bottle of 100) $472 10 payments
  6. JORNAY PM Central Nervous Stimulant ADHD $454 24 payments
  7. COTEMPLA XR-ODT $426 28 payments
  8. JORNAY PM Central Nervous System Stimulant $389 22 payments
  9. BEXSERO $318 9 payments
  10. Ragwitek $295 18 payments
  11. Other $4,891 266 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

397 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatrics in Alabama

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record